Retatrutide is at the Phase 3 stage, and the cagrilintide-plus-semaglutide combination CagriSema was reported to have a New Drug Application under FDA review, but a filing under review is not an approval
We used three separate approaches to examine the necessity of GGT1 to sustain GSH catabolism and cysteine supply to cancer cells
An important issue remains to be addressed
In the central nervous system, GLP-1 RAs regulate response to food cues and decrease food intake
Blood glucose levels were then monitored at 15, 30, 60, 90 and 120 minutes
Upon activation, the receptor triggers intracellular signaling cascades, mainly via cyclic adenosine monophosphate (cAMP) production and protein kinase A (PKA) activation